{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/124-US9,335,321(active).pdf"}, "page_content": "Whole mount in situ hybridization can be carried out as described by Westerfield (1994) with modifications (Cheng et 2000): Embryos at 24 hpfare to be dechorionated by using pair of forceps and fixed in PBS (phosphate-buffered saline) with 4% paraformaldehyde (PFA) and 1% Triton X-100 at 4\u00b0 overnight. Briefly, antisense RNA is then synthesized by linearising the plasmid and transcribing with T7 polymerase and Digoxigenin-11-UTP (Roche, Basel, Switzerland). The\n\nIn addition\n\nvisual\n\nmolecu-\n\nof 0.5 pg/ul.\n\nal.\n\na\n\nC.\n\n25\n\n40\n\n45\n\n50\n\nshould be transferred\n\nmethanol and stored\n\nEmbryos treated with agents (15 replicates) are pooled into\n\ncytometry analysis.\n\nparameter is the ratio of the power value of the basic fre-\n\nUS 9,335,321 B2\n\n10\n\nquency component to the total power value of the whole\n\nHasan, J., Shnyder, S. D., Bibby, M., Double, J. A., Bicknel,\n\nR. and Jayson, G. C. (2004). Quantitative Angiogenesis\n\nspectrum. This ratio is correlated with the heartbeat rhyth\n\nmicity.\n\nAssays in Vivo-a Review. Angiogenesis 7, 1-16.\n\nKidd, K. R. and Weinstein, B. M. (2003). Fishing for Novel\n\nAngiogenic Therapies. Br. J. Pharmacol. 140, 585-594.\n\n2. Results\n\nLawson, N. D. and Weinstein, B.M. (2002). In Vivo Imaging\n\nof Embryonic Vascular Development using Transgenic\n\na. Tier 1\n\nZebrafish. Dev. Biol. 248, 307-318.\n\nTotally, 1431 single compounds, 107 herbs singularly and\n\nLiekens, S., De Clercq, E. and Neyts, J. (2001). Angiogenesis:\n\n13 formulas had been screened in tier 1. These agents were\n\nRegulators and Clinical Applications. Biochem. Pharma\n\n10\n\nchosen from books of Traditional Chinese Medicine. Out of\n\ncol. 61,253-270.\n\n1431 compounds, there were 11 showing anti-angiogenic\n\nParng, C. Seng, W. L., Semino, C. and McGrath, P. (2002).\n\nmodulating activity at least in one of the tested concentra\n\nZebrafish: A Preclinical Model for Drug Screening. Assay\n\ntions. The phenomenon of anti-angiogenesis was the absence\n\nDrug Dev Technol. 1, 41-48.", "type": "Document"}}